Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.70%
#2 aelf aelf +23.60%
#3 Venom Venom +19.06%
#4 Decred Decred +11.55%
#5 Bitway Bitway +10.60%
#6 Pons Pons +10.32%
#7 Wibx Wibx +8.11%
#8 MarsCoin MarsCoin +7.93%
#9 Janction Janction +7.67%
#10 Status Status +7.65%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Vectorite Biomedical Inc. Vectorite Biomedical Inc.

Vectorite Biomedical Inc.

4170
Rang in aandelen #30413
Vectorite Biomedical Inc., established in 1993 and based in New Taipei City,... Vectorite Biomedical Inc., established in 1993 and based in New Taipei City, Taiwan, is a biotechnology firm dedicated to research and development activities globally, including a strong presence in its home country. The company's operations encompass the manufacturing of specialized cell preparation products, in addition to providing full-spectrum services for the collection, processing, and secure storage management of immune cells. These advanced cellular preparations are vital for applications in the medical fields of infectious diseases, inflammatory conditions, and various oncological and tumor-related illnesses.
Aandeelprijs
$0.392718
Marktkapitalisatie
$17.19M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-8.65%
Land
TW
Handel Vectorite Biomedical Inc. (4170)

Categorie

Healthcare
Winst voor Vectorite Biomedical Inc. (4170)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Vectorite Biomedical Inc. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Vectorite Biomedical Inc. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE